SCHEMBL23313266

SCHEMBL23313266

CCc1nc2cc(OC[C@@H]3C[C@H](F)[C@H](n4cc(-c5ccn(C)n5)c5c(N)ncnc54)O3)ccc2o1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ METTL3 Q86U44 13/20 0.60
▸ PRMT5 O14744 10/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25015953 0.85 METTL3 (0.81) METTL3PRMT5
SCHEMBL25017607 0.84 METTL3 (0.75) METTL3PRMT5
SCHEMBL25015993 0.83 METTL3 (0.70) METTL3PRMT5
SCHEMBL23313243 0.82 METTL3 (0.57) METTL3PRMT5
SCHEMBL23313237 0.81 METTL3 (0.49) METTL3PRMT5
SCHEMBL25017613 0.75 METTL3 (1.00) METTL3PRMT5
SCHEMBL24628056 0.73 PRMT5 (1.00) METTL3PRMT5
SCHEMBL23313050 0.72 METTL3 (0.90) METTL3PRMT5
SCHEMBL23313081 0.71 PRMT5 (1.00) METTL3PRMT5
SCHEMBL23313264 0.71 PRMT5 (0.79) METTL3PRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021079196-A9 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2022-07-14 — — WO disclosed
WO-2021079196-A2 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2021-04-29 — — WO disclosed
Send feedback